Cancer Chemotherapy and Pharmacology : Impact Factor & More
eISSN: 1432-0843pISSN: 0344-5704
Share this on:
Aims and Scope of Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media. The editors-in-chief are E.Chatelut (Paul Sabatier University) and E.A. Sausville (University of Maryland). It has been included in Index medicus (MEDLINE) since its first issue. According to the ISI 2016 Journal Citation Reports, the journal has an impact factor of 2.737, and its ranking was 98/254 (Pharmacology & Pharmacy) and 122/217 (Oncology). Less
Key Metrics
CiteScore 
5.9
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.96
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1978 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Chemotherapy and Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Chemotherapy and Pharmacology
Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer.
- 8 Dec 2025
- Cancer chemotherapy and pharmacology
Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib).
- 5 Dec 2025
- Cancer chemotherapy and pharmacology
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer.
- 4 Dec 2025
- Cancer chemotherapy and pharmacology
6-gingerol alleviates chemotherapy-induced nausea and vomiting by inhibiting ferroptosis via the regulation of iron homeostasis.
- 3 Dec 2025
- Cancer chemotherapy and pharmacology
Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions.
- 3 Dec 2025
- Cancer chemotherapy and pharmacology
Potential clinical relevance of rare dihydropyrimidine dehydrogenase genetic variants identified using whole-exome NextGen sequencing in cancer patients with severe fluoropyrimidine toxicity.
- 1 Dec 2025
- Cancer chemotherapy and pharmacology
Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer.
- 8 Dec 2025
- Cancer chemotherapy and pharmacology
Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib).
- 5 Dec 2025
- Cancer chemotherapy and pharmacology
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer.
- 4 Dec 2025
- Cancer chemotherapy and pharmacology
6-gingerol alleviates chemotherapy-induced nausea and vomiting by inhibiting ferroptosis via the regulation of iron homeostasis.
- 3 Dec 2025
- Cancer chemotherapy and pharmacology
Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions.
- 3 Dec 2025
- Cancer chemotherapy and pharmacology
Potential clinical relevance of rare dihydropyrimidine dehydrogenase genetic variants identified using whole-exome NextGen sequencing in cancer patients with severe fluoropyrimidine toxicity.
- 1 Dec 2025
- Cancer chemotherapy and pharmacology
FAQs on Cancer Chemotherapy and Pharmacology
How long has Cancer Chemotherapy and Pharmacology been actively publishing? 
What is the publishing frequency of Cancer Chemotherapy and Pharmacology?
How many articles did Cancer Chemotherapy and Pharmacology publish last year?
What is the eISSN & pISSN for Cancer Chemotherapy and Pharmacology?
What is Citescore for Cancer Chemotherapy and Pharmacology?
What is SNIP score for Cancer Chemotherapy and Pharmacology?
What is the SJR for Cancer Chemotherapy and Pharmacology?
Who is the publisher of Cancer Chemotherapy and Pharmacology?
